Topic desk · 2 reviewed briefs
Longevity and cellular signaling
Distinguish cell-line, mitochondrial, telomere, and biomarker research from evidence that people live longer or healthier.
Evidence boundary
A mechanism can be worth studying without establishing a lifespan, healthspan, or disease-prevention outcome.
- Reviewed briefs
- 2
- Established contexts
- 0
- Reviewed claims
- 6
Before accepting a claim
Ask the question the promotion leaves out.
- 01
Was the evidence generated in a dish, an animal, or a treated human?
- 02
Is the intervention in the paper identical to the marketed product?
- 03
Was any patient-centered aging outcome measured?
Connected briefs
Compare evidence without flattening it.
Preclinical or formulation evidenceInsufficient for reviewed context
MOTS-c
A mitochondria-derived peptide with active preclinical research but no established human drug-product outcomes or adequate clinical safety record.
3 reviewed claims · Open brief ↗Preclinical or formulation evidenceInsufficient for reviewed context
Epitalon
A tetrapeptide promoted for sleep and longevity despite identity transfer problems and no established insomnia or lifespan outcome evidence.
3 reviewed claims · Open brief ↗